Gilead Gets European CHMP's Positive Opinion For Epclusa For All Genotypes of Chronic Hepatitis C Treatment
May 27, 2016 at 10:57 AM EDT
Gilead Sciences, Inc. (NASDAQ: GILD) revealed that the Committee for Medicinal Products for Human Use (CHMP), European Medicines ...